| PANOVSKÁ, Anna, Yvona BRYCHTOVÁ, Gabriela VAŇKOVÁ, Boris TICHÝ, Šárka POSPÍŠILOVÁ, Jiří MAYER and Michael DOUBEK. Prognosis of relapsed chronic lymphocytic leukemia (CLL) after combined fludarabine, cyclophosphamide and rituximab (FCR) treatment. In 16th Congress of the European Hematology Association in Haematologica - the hematology journal. 2011. ISSN 0390-6078. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{960241,
author = {Panovská, Anna and Brychtová, Yvona and Vaňková, Gabriela and Tichý, Boris and Pospíšilová, Šárka and Mayer, Jiří and Doubek, Michael},
booktitle = {16th Congress of the European Hematology Association in Haematologica - the hematology journal},
language = {eng},
title = {Prognosis of relapsed chronic lymphocytic leukemia (CLL) after combined fludarabine, cyclophosphamide and rituximab (FCR) treatment.},
year = {2011}
}
TY - CONF
ID - 960241
AU - Panovská, Anna - Brychtová, Yvona - Vaňková, Gabriela - Tichý, Boris - Pospíšilová, Šárka - Mayer, Jiří - Doubek, Michael
PY - 2011
TI - Prognosis of relapsed chronic lymphocytic leukemia (CLL) after combined fludarabine, cyclophosphamide and rituximab (FCR) treatment.
ER -
PANOVSKÁ, Anna, Yvona BRYCHTOVÁ, Gabriela VAŇKOVÁ, Boris TICHÝ, Šárka POSPÍŠILOVÁ, Jiří MAYER and Michael DOUBEK. Prognosis of relapsed chronic lymphocytic leukemia (CLL) after combined fludarabine, cyclophosphamide and rituximab (FCR) treatment. In \textit{16th Congress of the European Hematology Association in Haematologica - the hematology journal}. 2011. ISSN~0390-6078.
|
